Loading…
Medline Inc. is projected to rise to $40.61 by 2027, a +13% move from its current price of $35.84. MDLN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $34.99 | $35.84 | $36.70 | -0.01% |
| May 30 | $34.64 | $35.83 | $37.06 | -0.02% |
| May 31 | $34.38 | $35.83 | $37.34 | -0.03% |
| Jun 1 | $34.15 | $35.82 | $37.58 | -0.05% |
| Jun 2 | $33.96 | $35.82 | $37.78 | -0.06% |
| Jun 3 | $33.78 | $35.82 | $37.97 | -0.07% |
| Jun 4 | $33.62 | $35.81 | $38.15 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $33.62 | $35.81 | $38.15 | -0.08% |
| Week 2 | $32.72 | $35.78 | $39.13 | -0.16% |
| Week 3 | $32.05 | $35.75 | $39.89 | -0.24% |
| Week 4 | $31.48 | $35.72 | $40.54 | -0.32% |
| Week 5 | $30.99 | $35.70 | $41.12 | -0.40% |
| Week 6 | $30.55 | $35.67 | $41.64 | -0.48% |
| Week 7 | $30.15 | $35.64 | $42.13 | -0.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medline Inc. manufactures med-surg products and serves hospitals, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.
The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products. It provides its products to domestic and international consumers.
The company was founded in 1966 and is based in Northfield, Illinois.
Medline Inc. (MDLN) is currently trading at $37.01 per share with a market cap of $31.3B and ranks 433. The stock sits within the healthcare sector and features two operating segments: Medline Brand and Supply Chain Solutions.
The near-term price outlook shows a path of gradual appreciation with a 2026 average around $37.01 and higher intermediate targets in subsequent years. The forecast highlights meaningful upside into 2030 and beyond, with a wide range of possible outcomes.
A major floor 23.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 34.7% above — a clean break opens room to run.
A major ceiling 46.2% above — clearing it would confirm fresh momentum.
Key MDLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $36.47 | Sell | $36.47 | Sell |
| MA 10 | $36.99 | Sell | $37.33 | Sell |
| MA 20 | $39.66 | Sell | $39.14 | Sell |
| MA 50 | $42.67 | Sell | $41.65 | Sell |
| MA 100 | $43.58 | Sell | $42.52 | Sell |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.58 | Neutral |
| Stoch RSI (14) | 50.36 | Neutral |
| CCI (20) | -89.73 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.25 | Sell |
| ROC (12) | -9.31 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.67 | Sell |
| Awesome (5,34) | -6.04 | Sell |
| Ultimate (7,14,28) | 37.64 | Neutral |
| Momentum (10) | -2.71 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 36.30 | Sell |
| ADX (14) | 28.69 | Sell |
| ATR (14) | 0.88 | Info |
The 30-day technical picture is bearish, with RSI(14) at 30 and the price trading below the SMA50 of $42.89. The current price sits near the lower end of the defined 30-day range, which spans $31.39 to $43.63. Key levels to watch are support at $36.02 and resistance at $48.26, indicating a trading corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $35.84 | $35.84 | $47.74 | 0% | Neutral | |
| $31.23 | $40.61 | $56.48 | +13% | Neutral | |
| $34.58 | $46.65 | $67.85 | +30% | Bullish | |
| $38.57 | $53.69 | $80.87 | +50% | Bullish | |
| $39.45 | $56.46 | $87.59 | +58% | Bullish | |
| $38.73 | $56.88 | $90.55 | +59% | Bullish | |
| $40.21 | $60.49 | $98.54 | +69% | Bullish | |
| $40.11 | $61.73 | $102.68 | +72% | Bullish | |
| $43.78 | $68.86 | $116.75 | +92% | Bullish | |
| $50.36 | $80.90 | $139.61 | +126% | Bullish | |
| $56.77 | $100.53 | $186.76 | +181% | Bullish | |
| $98.52 | $207.96 | $429.60 | +480% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $35.84 | $35.84 | $42.10 | +0.00% |
| June 2026 | $29.53 | $34.92 | $42.44 | -2.57% |
| July 2026 | $29.66 | $35.47 | $43.87 | +1.57% |
| August 2026 | $30.00 | $36.19 | $45.36 | +2.04% |
| September 2026 | $29.41 | $35.73 | $45.28 | -1.27% |
| October 2026 | $29.20 | $35.72 | $45.70 | -0.04% |
| November 2026 | $29.84 | $36.71 | $47.38 | +2.79% |
| December 2026 | $29.66 | $36.70 | $47.74 | -0.04% |
Click any year to see its month-by-month MDLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MDLN could reach as high as $47.74, with a base case around $35.84 and support toward $35.84 — roughly 0% from $35.84. Price action looks broadly range-bound.
Expect MDLN to range from $31.23 to $56.48 through 2027. The $40.61 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. A consolidation phase looks the most probable path here.
The MDLN price prediction for 2028 points to an average of $46.65 (low $34.58, high $67.85) — a potential gain of +30% on today's $35.84. Momentum favours further upside here.
In 2029, MDLN is projected to trade between $38.57 and $80.87, averaging $53.69 — a potential gain of +50% from today's $35.84. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Medline Inc.'s 2030 outlook centres on $56.46, within a $39.45 to $87.59 range. That is up +5% on the projected 2029 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2031, MDLN could reach as high as $90.55, with a base case around $56.88 and support toward $38.73 — roughly +59% from $35.84. Buyers look set to stay in control over this stretch.
Expect MDLN to range from $40.21 to $98.54 through 2032. The $60.49 average target implies a +69% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The MDLN price prediction for 2033 points to an average of $61.73 (low $40.11, high $102.68) — a potential gain of +72% on today's $35.84. Buyers look set to stay in control over this stretch.
In 2034, MDLN is projected to trade between $43.78 and $116.75, averaging $68.86 — a potential gain of +92% from today's $35.84. That is up +12% on the projected 2033 average. Momentum favours further upside here.
Medline Inc.'s 2035 outlook centres on $80.90, within a $50.36 to $139.61 range. That is up +17% on the projected 2034 average. That marks a +126% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MDLN could reach as high as $186.76, with a base case around $100.53 and support toward $56.77 — roughly +181% from $35.84. Momentum favours further upside here.
Expect MDLN to range from $98.52 to $429.60 through 2050. The $207.96 average target implies a +480% move from current prices. That is up +107% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MDLN today (≈ 27.901786 MDLN) could be worth
$5,802.58
+$4,802.58 (+480%) by 2050 · US Dollar
Based on the average projected MDLN price of $207.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDLNwould be worth at today's price.
$1,000 invested in MDLN on Dec 17, 2025 (≈ 24.390244 MDLN) would be worth
$874.15
-$125.85 (-12.6%) today · 0.87× · US Dollar
Based on a MDLN entry price of $41 vs. today's $35.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $36.25 | $988.69 | -1.1% |
| 1 month ago | $45.23 | $792.39 | -20.8% |
| 3 months ago | $48.89 | $733.07 | -26.7% |
| All time ago | $41 | $874.15 | -12.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDLN forecast.
Our base-case forecast reaches $72.00 around 2035.
Implied market cap at $72.00: $60.88B
The multi-year forecast shows a clear upward trajectory from 2026 through 2050. The 2027 average is $42.64 with ROI 15.2, followed by a 2028 average of $49.74 and ROI 34.4, and a 2029 average of $56.94 with ROI 53.8. By 2030 the average is projected at $60.25 (ROI 62.8), and 2031 at $60.88 (ROI 64.5).
The advance continues with 2032 at $64.54 (ROI 74.4) and 2033 at $66.59 (ROI 79.9), then 2034 at $74.93 (ROI 102.5) and 2035 at $87.98 (ROI 137.7). The long-range outlook shows 2040 with average $110.38 (ROI 198.2) and 2050 with average $229.83 (ROI 521). These figures imply a sustained bullish tilt over the horizon, though actual results depend on market conditions and are not guaranteed.
Tap a question to reveal the answer.
In 2026 the forecast shows min $36.02, avg $37.01, max $49.59, with ROI 0 and sentiment NEUTRAL.
The outlook shows a path of rising averages from 2026 onward, with 2027 avg $42.64 (ROI 15.2), 2028 avg $49.74 (ROI 34.4), and 2029 avg $56.94 (ROI 53.8), culminating in bullish long-run projections. These are estimates and not guarantees.
Yes, the forecasted max values exceed $100 in several years, for example 2033 max $112.33 and 2034 max $128.90, with later years like 2040 max $208.61 and 2050 max $484.32.
RSI(14) is 30 and the sentiment is BEARISH. The SMA50 is $42.89, with a 30-day range from $31.39 to $43.63. Support is at $36.02 and resistance at $48.26, and annualized volatility is 50%.
Medline Inc. Community Discussion
0Share your Medline Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.